G-21 V-Fast & V-Steady Bone Cement
Radiopaque PMMA bone-cement systems for vertebral consolidation, available in low-viscosity and immediate-viscosity formulations.
- Product type
- Vertebral Augmentation
- Application
- Vertebral consolidation / augmentation
- Manufacturer
- G-21 S.r.l.
- Regulatory
- V-Fast: TFDA No. 034271 / V-Steady: TFDA No. 034268
G-21 V-Fast & V-Steady Bone Cement
The G-21 vertebral-consolidation portfolio includes V-Fast and V-Steady. V-Fast is a low-viscosity bone cement with a long working time, while V-Steady is an immediate-viscosity bone cement with a long working time. Both are radiopaque PMMA-based cement systems supplied as powder and liquid components for mixing before use.
V-Fast: low viscosity and long working time
V-Steady: immediate viscosity and long working time
Radiopaque formulation
Powder-and-liquid PMMA cement system
Models & specifications
Configurations shown here are a website summary. Use the current approved product documentation for final model selection and procedural details.
| Product | Powder presentation | Liquid presentation | Key characteristic |
|---|---|---|---|
| V-Fast | 26 g | 10 mL | Low viscosity / long working time |
| V-Steady | 26 g | 10 mL | Immediate viscosity / long working time |
The sterile inner pouch is EO sterilized and intended for single use. Do not re-sterilize. Store sealed in the original packaging in a clean, dry environment at 5–25°C and protect from sunlight and heat.
Indications overview
The points below summarize the product family. Final patient selection and clinical use must follow the applicable approved labeling and Instructions for Use.
Vertebral consolidation procedures according to the approved Taiwan labeling
Use in vertebral augmentation workflows where PMMA bone cement is clinically indicated
Professional preparation and delivery according to the approved IFU
G-21 V-Fast & V-Steady Bone Cement
Product imagery is provided for portfolio identification. Model-specific components, dimensions and technique should be confirmed against current approved documentation.
Contact Summit Biomed →